27 related articles for article (PubMed ID: 7511901)
21. m-CPP: a tool for studying behavioural responses associated with 5-HT1c receptors.
Curzon G; Kennett GA
Trends Pharmacol Sci; 1990 May; 11(5):181-2. PubMed ID: 2188399
[No Abstract] [Full Text] [Related]
22. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
Czyrak A; Skuza G; Rogóz Z; Frankiewicz T; Maj J
Arzneimittelforschung; 1994 Feb; 44(2):113-8. PubMed ID: 7511901
[TBL] [Abstract][Full Text] [Related]
23. [The biochemical effect profile of zotepine in comparison with other neuroleptics].
Ackenheil M
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():2-9. PubMed ID: 1683335
[TBL] [Abstract][Full Text] [Related]
24. Brief comparison of the pharmacokinetics and pharmacodynamics of the traditional and newer antipsychotic drugs.
DeVane CL
Am J Health Syst Pharm; 1995 Feb; 52(3 Suppl 1):S15-8. PubMed ID: 7538435
[TBL] [Abstract][Full Text] [Related]
25. Zotepine: a clinical review.
Green B
Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):181-6. PubMed ID: 19199377
[TBL] [Abstract][Full Text] [Related]
26. Neuropharmacological supersensitivity-clinical and experimental correlates and methodological considerations.
Owen RT
Methods Find Exp Clin Pharmacol; 1980 Apr; 2(2):89-95. PubMed ID: 6121962
[TBL] [Abstract][Full Text] [Related]
27. Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans.
Murphy DL; Lesch KP; Aulakh CS; Pigott TA
Pharmacol Rev; 1991 Dec; 43(4):527-52. PubMed ID: 1775507
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
